Shah, P. K., Aushev, V. N., Ensor, J., Sanchez, S. A., Wang, C. G., Cannon, T. L., Berim, L. D., Feinstein, T., Grothey, A., McCollom, J. W., Kalmadi, S. R., Zakari, A., Dayyani, F., Gravenor, D., Liu, M. C., Jurdi, A. A., Aleshin, A., Meyer, J. M., Sharif, S., Kopetz, S. (2025). Circulating tumor DNA for detection of molecular residual disease (MRD) in patients (pts) with stage II/III colorectal cancer (CRC): Final analysis of the BESPOKE CRC sub-cohort.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.15